India  

Portable desi missile shield trial to begin soon

IndiaTimes Wednesday, 3 January 2024
The very short-range air defence system (VSHORADS), developed by DRDO to neutralise low-altitude aerial threats at ranges up to 6-km, "should be offered for user trials to the armed forces by April-May", a senior defence official told TOI. "The indigenously-developed 4th generation VSHORADS is technically superior to existing MANPADS (man-portable air defence systems) in the Indian armed forces because it has a state-of-the-art uncooled imaging infrared seeker," he said. VSHORADS offer a low-cost option that can swiftly be deployed for close air defence protection of crucial assets in rugged high-altitude areas as well as in the maritime domain.
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

Defence Research and Development Organisation Defence Research and Development Organisation Government agency in India

India's Successful Test of Hypersonic Missile Marks a New Era in Defense Technology| WATCH [Video]

India's Successful Test of Hypersonic Missile Marks a New Era in Defense Technology| WATCH

India has successfully test-fired its long-range hypersonic missile, joining a select group of countries including Russia and China. The missile, launched by the Defence Research and Development Organisation (DRDO) on November 16, 2024, can reach speeds over Mach 5 (more than 6,174 km/h) and target both sea and land-based objectives. This achievement underscores India's growing stature as a global military power. #IndiaHypersonic #DRDO #IndianDefense #MilitaryTechnology #HypersonicMissile #Mach5 #StrategicAdvantage #SelfReliance #GlobalDefense #IndiaRising #Oneindia #OneindiaNews ~HT.178~PR.362~ED.155~GR.124~

Credit: Oneindia    Duration: 06:01Published

The Times of India The Times of India Indian English-language daily newspaper

There's no proven drug yet to treat IPF, but there's hope

Idiopathic pulmonary fibrosis (IPF), the lung disease that claimed tabla maestro Zakir Hussain, is one of the most difficult conditions to treat because there is..
IndiaTimes